Full Paper
4.61–4.51 (m, 1H), 3.71–3.50 (m, 3H), 3.40–3.29 (m, 2H), 2.49–2.50
(m, 2H), 1.52 (s, 3H), 1.22 ppm (t, J=7.0 Hz, 3H); 13C NMR (75 MHz,
CDCl3): d=173.7, 138.1, 128.9, 128.1, 127.9, 127.6, 125.2, 80.9, 59.9,
53.5, 47.0, 38.7, 23.6, 16.4 ppm; IR (ATR): n˜ =3027, 2975, 2928,
1641, 1478, 1449, 1418, 1234 cmÀ1; HRMS (ESI): m/z calcd for
C16H21NO2: 259.1567 [M]+; found: 259.1572.
2.44 (m, 4H), 1.55 (s, 3H; m), 1.54 (s, 3H; M), 1.51 (d, J=7.0 Hz,
3H; M), 1.47 (d, J=7.0 Hz, 3H; m), 1.26 (t, J=7.0 Hz, 3H; M),
1.18 ppm (t, J=7.0 Hz, 3H; m); 13C NMR (75 MHz, CDCl3; M/m,
1.7:1): d=173.2 (M), 173.1 (m), 141.0 (m), 140.8 (M), 128.6, 128.4,
127.9, 127.5,127.4, 127.3, 127.2, 125.7 (m), 125.3 (M), 81.0 (m), 80.8
(M), 59.9 (m), 59.6 (M), 52.4 (M+m), 41.0 (M), 40.9 (m), 38.8 (m),
38.6 (M), 23.5 (M), 23.5 (m), 16.4 (M), 16.1 (M), 16.1 (m), 16.0 ppm
(m); IR (ATR): n˜ =3026, 2975, 2934, 2901, 1634, 1464, 1415, 1369,
1318, 1205, 1103, 1056, 828, 779, 753, 699, 647 cmÀ1; HRMS (ESI):
m/z calcd for C17H23NNaO2: 296.1621 [M+Na]+; found: 296.1618.
3-Ethoxy-1-(4-methoxybenzyl)-3-methyl-3,4-dihydroazepinone
(16b): Following the general procedure, from carbene complex
15a (100mg, 0.38mmol) and vinylaziridine 11 b (60mg,
0.32mmol), dihydroazepinone 16b was obtained as a yellow oil
1
(83mg, 91%). H NMR (300 MHz, CDCl3): d=7.17 (d, J=8.5 Hz, 2H),
3-Cyclopropyl-3-ethoxy-1-[(R)-1-phenylethyl]-3,4-dihydroazepi-
none, from 2-epi-11d (16e and 3-epi-16e): Following the general
procedure, from carbene complex 15b (80mg, 0.28mmol) and vi-
nylaziridine 2-epi-11 d (40mg, 0.23mmol), an inseparable mixture
of dihydroazepinone 16d and 3-epi-16d (1.4:1) was obtained as
6.83 (d, J=8.5 Hz, 2H), 5.68–5.49 (m, 2H), 4.59 (s, 2H), 4.55–4.44
(m, 1H), 3.78 (s, 3H), 3.69–3.56 (m, 1H), 3.39–3.27 (m, 2H), 2.54–
2.39 (m, 2H), 1.50 (s, 3H), 1.19 ppm (t, J=7.0 Hz, 3H); 13C NMR
(75 MHz, CDCl3): d=173.6, 159.2, 130.2, 129.5, 127.8, 125.2, 114.2,
80.9, 59.9, 55.6, 52.8, 46.7, 38.7, 23.5, 16.3 ppm; IR (ATR): n˜ =2973,
2928, 1638, 1511, 1476, 1444, 1394, 1349, 1301, 1242, 1172, 1104,
1060, 822, 639 cmÀ1; HRMS (ESI): m/z calcd for C17H24NO3: 290.1751
[M+H]+; found: 290.1747.
1
a green oil (69mg, quantitative yield). H NMR (300 MHz, CDCl3; M/
m, 1.4:1): d=7.36–7.25 (m, 5H), 6.23–6.07 (m, 1H), 5.74–5.33 (m,
2H), 4.35–4.04 (m, 1H), 3.97–3.40 (m, 2H), 3.27–3.06 (m, 1H), 2.25–
1.86 (m, 2H), 1.78–1.68 (m, 1H), 1.55–1.43 (m, 3H), 1.29–1.17 (m,
3H), 0.78–0.46 ppm (m, 4H); 13C NMR (75 MHz, CDCl3): d=173.7,
173.5, 141.3, 141.1, 128.8, 128.6, 127.7, 127.6, 127.5, 127.3, 126.9,
126.0, 125.7, 82.1, 81.9, 77.9, 59.8, 59.6, 52.8, 52.7, 41.6, 32.2, 31.9,
17.0, 16.8, 16.6, 16.4, 16.2, 4.6, 4.5 ppm; IR (ATR): n˜ =3017, 1639,
3-Ethoxy-1-(4-methoxyphenyl)-3-methyl-3,4-dihydroazepinone
(16c): Following the general procedure, from carbene complex
15a (100mg, 0.38mmol) and vinylaziridine 11 c (55mg,
0.315mmol), dihydroazepinone 16c was obtained as a yellow oil
(79mg, 91%). 1H NMR (300 MHz, CDCl3): d=7.09 (dd, J=8.6,
1.5 Hz, 2H), 6.88 (dd, J=8.6, 1.6 Hz, 2H), 5.90–5.66 (m, 2H), 5.07–
4.95 (m, 1H), 3.80 (s, 3H), 3.77–3.69 (m, 2H), 3.59–3.47 (m, 1H),
2.65–2.47 (m, 2H), 1.51 (s, 3H), 1.33 ppm (t, J=7.0 Hz, 3H);
13C NMR (75 MHz, CDCl3): d=173.6, 158.3, 139.3, 128.4, 127.7,
125.3, 114.6, 81.0, 60.0, 55.8, 50.8, 38.8, 23.3, 16.4 ppm; IR (ATR):
n˜ =2975, 2932, 2839, 1653, 1508, 1455, 1400, 1370, 1327, 1294,
1243, 1059, 1032, 828, 636 cmÀ1; HRMS (ESI): m/z calcd for
C16H22NO3: 276.1594 [M+H]+; found: 276.1600.
1496, 1061, 730 cmÀ1
; HRMS (ESI): m/z calcd for C19H26NO2:
300.1958 [M+H]+; found: 300.1964.
1-Benzyl-3-cyclopropyl-3-ethoxy-3,4-dihydroazepinone
(16 f):
Following the general procedure, from carbene complex 15b
(46mg, 0.16mmol) and vinylaziridine 11 a (21mg, 0.13mmol), dihy-
droazepinone 16e was obtained as a colorless oil (22mg, 61%).
1H NMR (300 MHz, CDCl3): d=7.35–7.22 (m, 5H), 5.70–5.52 (m, 2H),
4.76–4.63 (m, 2H), 4.57–4.46 (m, 1H), 3.93–3.83 (m, 1H), 3.47–3.36
(m, 2H), 2.24–1.96 (m, 2H), 1.74–1.63 (m, 1H), 1.23 (t, J=7.0 Hz,
3H), 0.77–0.67 (m, 1H), 0.65–0.48 ppm (m, 3H); 13C NMR (75 MHz,
CDCl3): d=173.9, 138.2, 128.9, 128.2, 127.6, 127.0, 125.4, 81.8, 59.7,
53.7, 47.4, 31.9, 16.8, 16.3, 4.4, 1.0 ppm; IR (ATR): n˜ =3084, 3032,
2974, 2920, 1643, 1476, 1450, 1350, 1230, 1167, 1089, 840,
3-Ethoxy-3-methyl-1-[(R)-1-phenylethyl]-3,4-dihydroazepinone,
from 11d (16d and 3-epi-16d): Following the general procedure,
from carbene complex 15a (43mg, 0.16mmol) and vinylaziridine
11 d (23mg, 0.13mmol), an inseparable mixture of dihydroazepi-
none 16d and 3-epi-16d (1:2.5) was obtained as a yellow oil
(35mg, quantitative yield). 1H NMR (300 MHz, CDCl3; m/M, 1:2.5):
d=7.42–7.20 (m, 10H), 6.25–5.98 (m, 2H), 5.85–5.62 (m, 1H; M),
5.65–5.50 (m, 1H; M), 5.56–5.42 (m, 1H; m), 5.40–5.30 (m, 1H; m),
4.37–4.25 (m, 1H; m), 4.21–4.04 (m, 1H; M), 3.79–3.59 (m, 2H),
3.48–3.26 (m, 2H), 3.16 (dd, J=16.7, 7.5 Hz, 1H; m), 3.07 (dd, J=
17.3, 7.6 Hz, 1H; M), 2.59–2.41 (m, 4H), 1.55 (s, 3H; M), 1.54 (s, 3H;
m), 1.50 (d, J=7.0 Hz, 3H; m), 1.46 (d, J=7.0 Hz, 3H; M), 1.25 (t,
J=7.0 Hz, 3H; m), 1.17 ppm (t, J=7.0 Hz, 3H; M); 13C NMR
(75 MHz, CDCl3; m/M, 1:2.5): d=173.5 (m), 173.3 (M), 141.3 (M),
141.1 (m), 128.8, 128.6, 128.2, 127.6, 127.5, 126.0 (M), 125.6 (m),
81.2 (M), 81.0 (m), 60.2 (M), 59.9 (m), 52.6 (M), 52.6 (m), 41.3 (m),
41.2 (M), 39.1 (M), 38.8 (m), 23.8 (m), 23.7 (M), 16.6 (m), 16.4 (M+
m), 16.3 ppm (M); IR (ATR): n˜ =3025, 2975, 2934, 2901, 1635, 1466,
1415, 1370, 1254, 1205, 1173, 1104, 1060, 920, 828, 778, 743, 700,
734 cmÀ1
; HRMS (ESI): m/z calcd for C18H23NNaO2: 308.1626
[M+Na]+; found: 308.1626.
1-Benzyl-3-butyl-3-ethoxy-3,4-dihydroazepinone (16g): Follow-
ing the general procedure, from carbene complex 15c (100mg,
0.32mmol) and vinylaziridine 11 a (42mg, 0.26mmol), dihydroaze-
pinone 16 f was obtained as a colorless oil (73mg, quantitative
yield). 1H NMR (300 MHz, CDCl3): d=7.34–7.22 (m, 5H), 5.69–5.55
(m, 2H), 4.73 (d, J=14.9 Hz, 1H), 4.64–4.54 (m, 2H), 3.55–3.46 (m,
1H), 3.39–3.25 (m, 2H), 2.60 (dt, J=18.6, 3.6 Hz, 1H), 2.38–2.27 (m,
1H), 2.20–2.08 (m, 1H), 1.81–1.72 (m, 1H), 1.42–1.33 (m, 4H), 1.22
(t, J=7.0 Hz, 3H), 0.95 ppm (t, J=6.8 Hz, 3H); 13C NMR (75 MHz,
CDCl3): d=173.9, 138.2, 128.9, 128.2, 127.7, 127.59, 125.33, 82.3,
59.2, 53.6, 47.1, 35.3, 34.1, 25.4, 23.6, 16.1, 14.6 ppm; IR (ATR): n˜ =
3026, 2957, 2827, 2869, 1642, 1475, 1450, 1417, 1232, 1166, 1106,
804, 730, 698 cmÀ1
; HRMS (ESI): m/z calcd for C19H27NNaO2:
324.1939 [M+Na]+; found: 324.1938.
648 cmÀ1
;
HRMS (ESI): m/z calcd for C17H23NNaO2: 296.1621
[M+Na]+; found: 296.1619.
1-Benzyl-3-ethoxy-3-methyl-3,4,7,8-tetrahydroazocinone (20a):
Following the general procedure, from carbene complex 15a
(120mg, 0.46mmol) and vinylazetidine 17a (66mg, 0.38mmol), tet-
rahydroazocinone 20a was obtained as a colorless oil (67mg,
64%). 1H NMR (300 MHz, CDCl3): d=7.36–7.21 (m, 5H), 5.77–5.65
(m, 1H), 5.57–5.46 (m, 1H), 5.06 (d, J=14.7 Hz, 1H), 4.67–4.54 (m,
1H), 3.95 (d, J=14.7 Hz, 1H), 3.66–3.56 (m, 1H), 3.28 (dq, J=9.0,
7.0 Hz, 1H), 3.17–3.07 (m, 1H), 2.78 (dd, J=13.6, 9.7 Hz, 1H), 2.45–
2.28 (m, 3H), 1.54 (s, 3H), 1.15 ppm (t, J=7.0 Hz, 3H); 13C NMR
(75 MHz, CDCl3): d=173.8, 138.3, 129.2, 128.8, 128.5, 127.6, 127.2,
83.3, 60.4, 49.8, 44.4, 41.9, 26.6, 25.3, 16.1 ppm; IR (ATR): n˜ =3026,
3-Ethoxy-3-methyl-1-[(R)-1-phenylethyl]-3,4-dihydroazepinone,
from 2-epi-11d (16d and 3-epi-16d): Following the general proce-
dure, from carbene complex 15a (57mg, 0.22mmol) and vinylaziri-
dine 2-epi-11 d (31mg, 0.18mmol), an inseparable mixture of dihy-
droazepinone 16d and 3-epi-16d (1.7:1) was obtained as a yellow
oil (29mg, 58%). 1H NMR (300 MHz, CDCl3; M/m, 1.7:1): d=7.39–
7.23 (m, 10H), 6.21–6.05 (m, 2H), 5.80–5.67 (m, 1H; m), 5.66–5.54
(m, 1H; m), 5.54–5.45 (m, 1H; M), 5.41–5.31 (m, 1H; M), 4.38–4.26
(m, 1H; M), 4.19–4.06 (m, 1H; m), 3.77–3.60 (m, 2H), 3.44–3.28 (m,
2H), 3.17 (dd, J=16.8, 7.7 Hz, 1H; M), 3.12–3.02 (m, 1H; m), 2.55–
Chem. Eur. J. 2014, 20, 1359 – 1366
1364
ꢁ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim